Life Sciences Times

KalVista Drug for Hereditary Angioedema Keeps Orphan Status in EU

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Tandem Diabetes Care Issues Voluntary Correction for Select t:slim X2 Insulin Pumps Due to Malfunction Risk

BostonGene Wins “AI-based Drug Discovery Solution of the Year” at 2025 AI Breakthrough Awards

Ametros Strengthens Leadership Team with Two Key Hires to Enhance Member Services

Vivio System Enables Early, Non-Invasive Detection of Heart Failure in Primary Care, Study Finds

Apreo Health Raises $130 Million in Series B to Advance Trial and Commercialization of Novel Emphysema Device

ThinkBio.Ai and UST Form Strategic Partnership to Advance AI Solutions for Biopharma and Healthcare

Palleon Pharmaceuticals Doses First Patient in Phase 2 Trial of E-602 for Autoimmune Kidney Disease

Strand Therapeutics Secures $153 Million in Series B to Accelerate Programmable mRNA Therapy Pipeline